Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 6/2019

29.10.2019 | Original Article

Preoperative total cholesterol-lymphocyte score as a novel immunonutritional predictor of survival in gastric cancer

verfasst von: Daiki Matsubara, Katsutoshi Shoda, Takeshi Kubota, Toshiyuki Kosuga, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Michihiro Kudou, Tomohiro Arita, Ryo Morimura, Yasutoshi Murayama, Hisashi Ikoma, Yoshiaki Kuriu, Masayoshi Nakanishi, Eigo Otsuji

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Immunonutritional status is a known prognostic correlate in the context of gastric cancer (GC). In the present study, we investigated the prognostic relevance of a lipid profile-based immunonutritional score in patients with GC.

Methods

Data pertaining to 224 patients with stage II and III GC who underwent curative gastrectomy were retrospectively analyzed. The total cholesterol-lymphocyte score (TL score) was defined as follows: patients with both low total cholesterol (TC) and total lymphocyte count were allocated a score of 2; patients with only one or none of these biochemical abnormalities were allocated a score of 1 or 0, respectively.

Results

Among the serum lipid indices, low TC was the strongest predictor of cancer-specific survival (CSS; p = 0.001). On multivariate analysis, both low prognostic nutritional index (PNI) (p < 0.001) and high TL score (p = 0.003) were independent prognostic factors. PNI was significantly associated with peritoneal recurrence (p = 0.047), while TL score was significantly associated with locoregional and distant metastasis (p = 0.004 and p = 0.003, respectively).

Conclusions

TL score may facilitate risk stratification of patients based on CSS. TL score plus PNI may help predict the recurrence pattern in patients with stage II and III GC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef
2.
Zurück zum Zitat Heys SD, Park KG, Garlick PJ et al (1992) Nutrition and malignant disease: implications for surgical practice. Br J Surg 79:614–623CrossRef Heys SD, Park KG, Garlick PJ et al (1992) Nutrition and malignant disease: implications for surgical practice. Br J Surg 79:614–623CrossRef
3.
Zurück zum Zitat Miyata H, Yano M, Yasuda T et al (2012) Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr 31:330–336CrossRef Miyata H, Yano M, Yasuda T et al (2012) Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr 31:330–336CrossRef
4.
Zurück zum Zitat Heys SD, Park KG, Garlick PJ et al (1992) Nutrition and malignant disease: implications for surgical practice. Br J Surg 79(7):614–623CrossRef Heys SD, Park KG, Garlick PJ et al (1992) Nutrition and malignant disease: implications for surgical practice. Br J Surg 79(7):614–623CrossRef
6.
Zurück zum Zitat Pinato DJ, North BV, Sharma R et al (2012) A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer 106:1439–1445CrossRef Pinato DJ, North BV, Sharma R et al (2012) A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer 106:1439–1445CrossRef
12.
Zurück zum Zitat Toyokawa T, Kubo N, Tamura T et al (2016) The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer 6(16):722. https://doi.org/10.1186/s12885-016-2696-0 CrossRef Toyokawa T, Kubo N, Tamura T et al (2016) The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer 6(16):722. https://​doi.​org/​10.​1186/​s12885-016-2696-0 CrossRef
15.
Zurück zum Zitat Japanese Gastric Cancer Association 2014. Japanese Gastric Cancer Treatment Guidelines 2014 (version 4). Tokyo Japanese Gastric Cancer Association 2014. Japanese Gastric Cancer Treatment Guidelines 2014 (version 4). Tokyo
16.
Zurück zum Zitat Brierley JD, Gospodarowicz MK, Wittekind C (2017) editors. Union for International Cancer Control. TNM Classification of Malignant Tumors. 8th ed. Wiley, New York Brierley JD, Gospodarowicz MK, Wittekind C (2017) editors. Union for International Cancer Control. TNM Classification of Malignant Tumors. 8th ed. Wiley, New York
18.
Zurück zum Zitat Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients [in Japanese]. Nippon Geka Gakkai Zasshi 85:1001–1005PubMed Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients [in Japanese]. Nippon Geka Gakkai Zasshi 85:1001–1005PubMed
19.
Zurück zum Zitat Ignacio de Ulíbarri J, González-Madroño A, de Villar NG et al (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp Jan-Feb 20(1):38–45 Ignacio de Ulíbarri J, González-Madroño A, de Villar NG et al (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp Jan-Feb 20(1):38–45
20.
Zurück zum Zitat Altman DG, Lausen B, Sauerbrei W et al (1994) Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829–835CrossRef Altman DG, Lausen B, Sauerbrei W et al (1994) Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829–835CrossRef
22.
Zurück zum Zitat Calleros L, Lasa M, Toro MJ et al (2006) Low cell cholesterol levels increase NFkappaB activity through a p38 MAPK-dependent mechanism. Cell Signal 18(12):2292–2301 Epub 2006 Jun 27CrossRef Calleros L, Lasa M, Toro MJ et al (2006) Low cell cholesterol levels increase NFkappaB activity through a p38 MAPK-dependent mechanism. Cell Signal 18(12):2292–2301 Epub 2006 Jun 27CrossRef
30.
36.
37.
Zurück zum Zitat Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T (2017) Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients. Langenbecks Arch Surg 402(3):501–507CrossRef Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T (2017) Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients. Langenbecks Arch Surg 402(3):501–507CrossRef
38.
Zurück zum Zitat Nam DH, Lee H, Park JC et al (2014) Long-term statin therapy improves oncological outcome after radical gastrectomy for stage II and III gastric cancer. Anticancer Res 34(1):355–361PubMed Nam DH, Lee H, Park JC et al (2014) Long-term statin therapy improves oncological outcome after radical gastrectomy for stage II and III gastric cancer. Anticancer Res 34(1):355–361PubMed
39.
Zurück zum Zitat Hatao F, Chen KY, Wu JM, Wang MY, Aikou S, Onoyama H, Shimizu N, Fukatsu K, Seto Y, Lin MT (2017) Randomized controlled clinical trial assessing the effects of oral nutritional supplements in postoperative gastric cancer patients. Langenbecks Arch Surg 402(2):203–211CrossRef Hatao F, Chen KY, Wu JM, Wang MY, Aikou S, Onoyama H, Shimizu N, Fukatsu K, Seto Y, Lin MT (2017) Randomized controlled clinical trial assessing the effects of oral nutritional supplements in postoperative gastric cancer patients. Langenbecks Arch Surg 402(2):203–211CrossRef
41.
Zurück zum Zitat Giger U, Büchler M, Farhadi J, Berger D, Hüsler J, Schneider H, Krähenbühl S, Krähenbühl L (2007) Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncol 14(10):2798–2806 Epub 2007 Jul 15CrossRef Giger U, Büchler M, Farhadi J, Berger D, Hüsler J, Schneider H, Krähenbühl S, Krähenbühl L (2007) Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncol 14(10):2798–2806 Epub 2007 Jul 15CrossRef
Metadaten
Titel
Preoperative total cholesterol-lymphocyte score as a novel immunonutritional predictor of survival in gastric cancer
verfasst von
Daiki Matsubara
Katsutoshi Shoda
Takeshi Kubota
Toshiyuki Kosuga
Hirotaka Konishi
Atsushi Shiozaki
Hitoshi Fujiwara
Kazuma Okamoto
Michihiro Kudou
Tomohiro Arita
Ryo Morimura
Yasutoshi Murayama
Hisashi Ikoma
Yoshiaki Kuriu
Masayoshi Nakanishi
Eigo Otsuji
Publikationsdatum
29.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 6/2019
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-019-01824-8

Weitere Artikel der Ausgabe 6/2019

Langenbeck's Archives of Surgery 6/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.